PNC Financial Services Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

PNC Financial Services Group’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-63	Closed	-$2.93K	–	4825
2023 Q2	$2.93K	Buy	+63	New	+$2.18K	﹤0.01%	4266

PNC Financial Services Group's DICE Position: Q3 2023 in Review

PNC Financial Services Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 63 shares — an estimated $2.93K sold.

PNC Financial Services Group first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $2.93K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

PNC Financial Services Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
PNC Financial Services Group sold 63 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.93K.
PNC Financial Services Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
PNC Financial Services Group's DICE Therapeutics, Inc. Common Stock position peaked at $2.93K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on PNC Financial Services Group's 13F filing for Q3 2023, filed 13 Nov 2023.